Acticoat Absorbent and BCT Antimicrobial for STSG Donor Site on Thigh
1 other identifier
interventional
70
1 country
1
Brief Summary
This study aims to compare the effectiveness of two wound dressings, Acticoat Absorbent (AA) and BCT Antimicrobial (BCT) on Split Thickness Skin Graft (STSG) donor site.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 10, 2013
CompletedFirst Posted
Study publicly available on registry
January 16, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2014
CompletedFebruary 21, 2013
January 1, 2013
6 months
January 10, 2013
February 20, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
wound healing rate
percentage of wound area that has healed at this time
7 days
wound infection rate
7 days
wound healing rate
percentage of wound area that has healed at this time
14 days
Secondary Outcomes (10)
scar appearance
1 month
pain and itchiness
1day
scar appearance
3 months
scar appearance
6 months
pain and itchiness
2 days
- +5 more secondary outcomes
Study Arms (2)
Acticoat Absorbent
ACTIVE COMPARATORActicoat Absorbent wound dressing
BCT wound dressing
EXPERIMENTALwound dressing
Interventions
Eligibility Criteria
You may qualify if:
- patients who need STSG, longer than 8 cm and wider than 5 cm, from their thighs
You may not qualify if:
- systemic steroid
- old scar on thigh
- systemic infection
- anticipated use of antibiotics for more than 24 hours after operation
- pregnancy
- previous chemotherapy within 3 months before operation
- anticipated chemotherapy within 3 months after operation
- not over 20 years old
- non-communicable
- burn area more than 20% total body surface area
- systemic auto-immune disease
- liver cirrhosis
- allergy to carbon fiber or alginate
- anticipated MRI study
- dry wound
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kaohsiung Veterans General Hospital
Kaohsiung City, 81362, Taiwan
Related Publications (8)
Klasen HJ. Historical review of the use of silver in the treatment of burns. I. Early uses. Burns. 2000 Mar;26(2):117-30. doi: 10.1016/s0305-4179(99)00108-4. No abstract available.
PMID: 10716354BACKGROUNDTrop M, Novak M, Rodl S, Hellbom B, Kroell W, Goessler W. Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J Trauma. 2006 Mar;60(3):648-52. doi: 10.1097/01.ta.0000208126.22089.b6.
PMID: 16531870BACKGROUNDVlachou E, Chipp E, Shale E, Wilson YT, Papini R, Moiemen NS. The safety of nanocrystalline silver dressings on burns: a study of systemic silver absorption. Burns. 2007 Dec;33(8):979-85. doi: 10.1016/j.burns.2007.07.014. Epub 2007 Oct 23.
PMID: 17959313BACKGROUNDTredget EE, Shankowsky HA, Groeneveld A, Burrell R. A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds. J Burn Care Rehabil. 1998 Nov-Dec;19(6):531-7. doi: 10.1097/00004630-199811000-00013.
PMID: 9848045RESULTArgirova M, Hadjiski O, Victorova A. Acticoat versus Allevyn as a split-thickness skin graft donor-site dressing: a prospective comparative study. Ann Plast Surg. 2007 Oct;59(4):415-22. doi: 10.1097/SAP.0b013e3180312705.
PMID: 17901734RESULTInnes ME, Umraw N, Fish JS, Gomez M, Cartotto RC. The use of silver coated dressings on donor site wounds: a prospective, controlled matched pair study. Burns. 2001 Sep;27(6):621-7. doi: 10.1016/s0305-4179(01)00015-8.
PMID: 11525858RESULTHuang Y, Li X, Liao Z, Zhang G, Liu Q, Tang J, Peng Y, Liu X, Luo Q. A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis. Burns. 2007 Mar;33(2):161-6. doi: 10.1016/j.burns.2006.06.020. Epub 2006 Dec 18.
PMID: 17175106RESULTMoiemen NS, Shale E, Drysdale KJ, Smith G, Wilson YT, Papini R. Acticoat dressings and major burns: systemic silver absorption. Burns. 2011 Feb;37(1):27-35. doi: 10.1016/j.burns.2010.09.006. Epub 2010 Oct 18.
PMID: 20961690RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kuei-Chang Hsu, MD
Kaohsiung Veterans General Hospital.
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant Surgeon
Study Record Dates
First Submitted
January 10, 2013
First Posted
January 16, 2013
Study Start
January 1, 2013
Primary Completion
July 1, 2013
Study Completion
April 1, 2014
Last Updated
February 21, 2013
Record last verified: 2013-01